These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31688905)

  • 1. Mechanistic definition of the cardiovascular mPGES-1/COX-2/ADMA axis.
    Kirkby NS; Raouf J; Ahmetaj-Shala B; Liu B; Mazi SI; Edin ML; Chambers MG; Korotkova M; Wang X; Wahli W; Zeldin DC; Nüsing R; Zhou Y; Jakobsson PJ; Mitchell JA
    Cardiovasc Res; 2020 Oct; 116(12):1972-1980. PubMed ID: 31688905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Role of mPGES-1 (Microsomal Prostaglandin E Synthase-1)-Derived PGE
    Hao H; Hu S; Wan Q; Xu C; Chen H; Zhu L; Xu Z; Meng J; Breyer RM; Li N; Liu DP; FitzGerald GA; Wang M
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1115-1124. PubMed ID: 29599139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory role of microsomal prostaglandin E synthase-1 in a model of neuroinflammation.
    Brenneis C; Coste O; Altenrath K; Angioni C; Schmidt H; Schuh CD; Zhang DD; Henke M; Weigert A; Brüne B; Rubin B; Nusing R; Scholich K; Geisslinger G
    J Biol Chem; 2011 Jan; 286(3):2331-42. PubMed ID: 21075851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsomal Prostaglandin E Synthase-1-Derived PGE2 Inhibits Vascular Smooth Muscle Cell Calcification.
    Gao C; Fu Y; Li Y; Zhang X; Zhang L; Yu F; Xu SS; Xu Q; Zhu Y; Guan Y; Wang X; Kong W
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):108-21. PubMed ID: 26543101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal expression of the PGE2 synthetic system in the kidney is associated with the time frame of renal developmental vulnerability to cyclooxygenase-2 inhibition.
    Frölich S; Olliges A; Kern N; Schreiber Y; Narumiya S; Nüsing RM
    Am J Physiol Renal Physiol; 2012 Jul; 303(2):F209-19. PubMed ID: 22573380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II differentially modulates cyclooxygenase-2, microsomal prostaglandin E2 synthase-1 and prostaglandin I2 synthase expression in adventitial fibroblasts exposed to inflammatory stimuli.
    Galán M; Miguel M; Beltrán AE; Rodríguez C; García-Redondo AB; Rodríguez-Calvo R; Alonso MJ; Martínez-González J; Salaices M
    J Hypertens; 2011 Mar; 29(3):529-36. PubMed ID: 21169864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of prostaglandin E2 synthases and E-prostanoid receptors in the spinal cord in a rat model of neuropathic pain.
    Kanda H; Kobayashi K; Yamanaka H; Okubo M; Dai Y; Noguchi K
    Brain Res; 2021 Jan; 1750():147153. PubMed ID: 33049240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coordinated action of microsomal prostaglandin E synthase-1 and prostacyclin synthase on contact hypersensitivity.
    Ochiai T; Sasaki Y; Kuwata H; Nakatani Y; Yokoyama C; Hara S
    Biochem Biophys Res Commun; 2021 Mar; 546():124-129. PubMed ID: 33582554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of microsomal PGE synthase-1 reduces human vascular tone by increasing PGI
    Ozen G; Gomez I; Daci A; Deschildre C; Boubaya L; Teskin O; Uydeş-Doğan BS; Jakobsson PJ; Longrois D; Topal G; Norel X
    Br J Pharmacol; 2017 Nov; 174(22):4087-4098. PubMed ID: 28675448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of microsomal prostaglandin E-synthase-1 (mPGES-1) selectively suppresses PGE
    Martin EM; Jones SL
    Vet Immunol Immunopathol; 2017 Oct; 192():33-40. PubMed ID: 29042013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)--a critical review.
    Koeberle A; Werz O
    Curr Med Chem; 2009; 16(32):4274-96. PubMed ID: 19754418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs.
    Ahmetaj-Shala B; Kirkby NS; Knowles R; Al'Yamani M; Mazi S; Wang Z; Tucker AT; Mackenzie L; Armstrong PC; Nüsing RM; Tomlinson JA; Warner TD; Leiper J; Mitchell JA
    Circulation; 2015 Feb; 131(7):633-42. PubMed ID: 25492024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of cyclooxygenase 2 and microsomal prostaglandin E synthase 1 in rat acid reflux oesophagitis.
    Hayakawa T; Fujiwara Y; Hamaguchi M; Sugawa T; Okuyama M; Sasaki E; Watanabe T; Tominaga K; Oshitani N; Higuchi K; Arakawa T
    Gut; 2006 Apr; 55(4):450-6. PubMed ID: 16210398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of microsomal prostaglandin E synthase-1 inhibition on resistance artery tone in patients with end stage kidney disease.
    Steinmetz-Späh J; Arefin S; Larsson K; Jahan J; Mudrovcic N; Wennberg L; Stenvinkel P; Korotkova M; Kublickiene K; Jakobsson PJ
    Br J Pharmacol; 2022 Apr; 179(7):1433-1449. PubMed ID: 34766335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic-deletion of Cyclooxygenase-2 Downstream Prostacyclin Synthase Suppresses Inflammatory Reactions but Facilitates Carcinogenesis, unlike Deletion of Microsomal Prostaglandin E Synthase-1.
    Sasaki Y; Kamiyama S; Kamiyama A; Matsumoto K; Akatsu M; Nakatani Y; Kuwata H; Ishikawa Y; Ishii T; Yokoyama C; Hara S
    Sci Rep; 2015 Nov; 5():17376. PubMed ID: 26611322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necrosis in DU145 prostate cancer spheroids induces COX-2/mPGES-1-derived PGE2 to promote tumor growth and to inhibit T cell activation.
    Sha W; Olesch C; Hanaka H; Rådmark O; Weigert A; Brüne B
    Int J Cancer; 2013 Oct; 133(7):1578-88. PubMed ID: 23536473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2, Asymmetric Dimethylarginine, and the Cardiovascular Hazard From Nonsteroidal Anti-Inflammatory Drugs.
    Ricciotti E; Castro C; Tang SY; Briggs WTE; West JA; Malik D; Rhoades SD; Meng H; Li X; Lahens NF; Sparks JA; Karlson EW; Weljie AM; Griffin JL; FitzGerald GA
    Circulation; 2018 Nov; 138(21):2367-2378. PubMed ID: 29930022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-inflammatory and vasoprotective properties of mPGES-1 inhibition offer promising therapeutic potential.
    Steinmetz-Späh J; Jakobsson PJ
    Expert Opin Ther Targets; 2023; 27(11):1115-1123. PubMed ID: 38015194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shunting of prostanoid biosynthesis in microsomal prostaglandin E synthase-1 null embryo fibroblasts: regulatory effects on inducible nitric oxide synthase expression and nitrite synthesis.
    Kapoor M; Kojima F; Qian M; Yang L; Crofford LJ
    FASEB J; 2006 Nov; 20(13):2387-9. PubMed ID: 17023389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders.
    Koeberle A; Werz O
    Biochem Pharmacol; 2015 Nov; 98(1):1-15. PubMed ID: 26123522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.